Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Hikaru Hori

Biographic Data

ID7664218
NAMEHikaru Hori
GIVEN NAMESHikaru
FAMILY NAMEHori
SIGNATUREHORI H
AFFILIATIONSFukuoka University
ORCID0000-0001-8179-3054
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
AUTHOR COUNT5
EDITOR COUNT0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepressants: A post hoc ana…

    Open Access•Hikaru Hori, Masako Shiosakai et al.•ARTICLE•Frontiers in Psychiatry•2025

    The MCIDs for the MADRS, SDS, and EQ-5D-5L -derived utility scores were estimated. Physicians focus more on depressive symptoms and prioritize symptom severity over improvements in functionality and activities of daily life, in contrast to patients, who prioritize such improvements

  • Bipolar disorder and Lewy body dementia: Case report and literature review

    Open Access•Sayuri Nakamura, Hiroko Sugawara et al.•ARTICLE•Frontiers in Psychiatry•2024

    Depressive episodes with psychotic symptoms are prevalent among the older adults, emphasizing the need to differentiate them from dementia with Lewy bodies (DLB), in which depressive and psychotic symptoms commonly coexist. In contrast, psychotic symptoms occur more frequently in depressive episodes of bipolar disorder (BD) than in major depressive disorder (MDD). Although MDD is a significant risk factor for dementia, studies exploring the relat…

  • Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

    Open Access•Hikaru Hori, Norio Yasui‐Furukori et al.•ARTICLE•Frontiers in Psychiatry•2022

    In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic prescription patterns and differences among hospitals. A cross-sectional, retrospective prescription survey at the time of discharge was conducted on 2027 patients with schizophrenia from 69 Japanese hospitals. We e…

  • Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study

    Open Access•Hikaru Hori, Asuka Katsuki et al.•ARTICLE•Frontiers in Psychiatry•2018

    The results of this preliminary study suggest that switching from oral risperidone to RLAI may improve verbal capability more than continuing with oral risperidone. However, these findings must be replicated in a larger, double-blind study

  • The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients

    Open Access•Kiyokazu Atake, Tomoyuki Nakamura et al.•ARTICLE•Frontiers in Psychiatry•2018

    Background: Cognitive impairment in schizophrenia can result in considerable difficulty in performing functions of daily life or social rehabilitation. Cognitive impairment in schizophrenia is related to various factors, such as the psychotic severity, aging, medication, and brain-derived neurotrophic factor (BDNF). To date, however, no studies investigating the impact of these factors on cognitive functioning in chronic schizophrenia patients ha…

No prominent works on this page.

  • Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study

    Open Access•Hikaru Hori, Asuka Katsuki et al.•ARTICLE•Frontiers in Psychiatry•2018

    The results of this preliminary study suggest that switching from oral risperidone to RLAI may improve verbal capability more than continuing with oral risperidone. However, these findings must be replicated in a larger, double-blind study

  • The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients

    Open Access•Kiyokazu Atake, Tomoyuki Nakamura et al.•ARTICLE•Frontiers in Psychiatry•2018

    Background: Cognitive impairment in schizophrenia can result in considerable difficulty in performing functions of daily life or social rehabilitation. Cognitive impairment in schizophrenia is related to various factors, such as the psychotic severity, aging, medication, and brain-derived neurotrophic factor (BDNF). To date, however, no studies investigating the impact of these factors on cognitive functioning in chronic schizophrenia patients ha…

  • Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

    Open Access•Hikaru Hori, Norio Yasui‐Furukori et al.•ARTICLE•Frontiers in Psychiatry•2022

    In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic prescription patterns and differences among hospitals. A cross-sectional, retrospective prescription survey at the time of discharge was conducted on 2027 patients with schizophrenia from 69 Japanese hospitals. We e…

  • Bipolar disorder and Lewy body dementia: Case report and literature review

    Open Access•Sayuri Nakamura, Hiroko Sugawara et al.•ARTICLE•Frontiers in Psychiatry•2024

    Depressive episodes with psychotic symptoms are prevalent among the older adults, emphasizing the need to differentiate them from dementia with Lewy bodies (DLB), in which depressive and psychotic symptoms commonly coexist. In contrast, psychotic symptoms occur more frequently in depressive episodes of bipolar disorder (BD) than in major depressive disorder (MDD). Although MDD is a significant risk factor for dementia, studies exploring the relat…

  • Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepressants: A post hoc ana…

    Open Access•Hikaru Hori, Masako Shiosakai et al.•ARTICLE•Frontiers in Psychiatry•2025

    The MCIDs for the MADRS, SDS, and EQ-5D-5L -derived utility scores were estimated. Physicians focus more on depressive symptoms and prioritize symptom severity over improvements in functionality and activities of daily life, in contrast to patients, who prioritize such improvements

Internal Medicine (5 works) · Medicine (5 works) · Psychiatry (5 works) · Cognition (4 works) · Psychology (4 works) · Schizophrenia research and treatment (4 works) · Clinical Psychology (3 works) · Clinical Psychology (3 works) · Antipsychotic (2 works) · Depression (economics (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae